UK MHRA may restrict AstraZeneca shot for younger people – Channel 4
|The UK’s Medicines and Healthcare products Regulatory Agency is considering outlining a proposal, which will restrict the use of the Oxford-AstraZeneca covid vaccine in younger people over concerns about very rare blood clots, Channel 4 News reported, citing two senior sources.
“Two senior sources have told this programme that while the data is still unclear there are growing arguments to justify offering younger people - below the age of 30 at the very least - a different vaccine,” the media outlet reported.
Recall that the British medical regulator had previously said that the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots.
Market reaction
Markets ignore the above piece of news, as the risk sentiment recovers in early Asia, reflected by the uptick in the S&P 500 futures.
GBP/USD rises 0.10% on the day, trading at 1.3911, as of writing.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.